⌘K

Login Start Free

Home/Filings/4/0001127602-23-023693

4//SEC Filing

HEGGIE THERESA 4

Accession 0001127602-23-023693

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:41 PM ET

Size

4.4 KB

Accession

0001127602-23-023693

Insider Transaction Report

Form 4

Period: 2023-08-31

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Award
Common Stock
2023-08-31$7.11/sh+791$5,624→ 49,905 total

Footnotes (1)

[F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001760020

Filing Metadata

Form type: 4
Filed: Sep 4, 8:00 PM ET
Accepted: Sep 5, 4:41 PM ET
Size: 4.4 KB

View on SEC.gov